Our company has achieved ISO 14067 certification for Carbon Footprint verification, marking a significant milestone in our sustainability journey and reinforcing our commitment to responsible pharmaceutical manufacturing.
With this achievement, we now hold a complete portfolio of four internationally recognized ISO certifications, covering:
- Environmental Management (ISO 14001)
- Occupational Health & Safety (ISO 45001)
- Energy Management (ISO 50001)
- Carbon Footprint Verification (ISO 14067)
This distinction places our operations among a very limited number of pharmaceutical manufacturers in Japan to meet such a comprehensive set of global standards, and uniquely positions us as a benchmark for sustainable API production within our region.
A Commitment Aligned with Responsible API Manufacturing
As a producer of bile-derived active pharmaceutical ingredients, our processes demand precision, traceability, and environmental responsibility. Achieving ISO 14067 certification reflects our ability to quantify, verify, and actively reduce carbon emissions across our value chain—while maintaining the highest standards of quality and compliance expected by global pharmaceutical partners.
Driven by People, Guided by Purpose
This accomplishment is the result of the dedication and expertise of our team, whose continuous efforts ensure that sustainability is embedded into daily operations—not treated as an afterthought. It also reflects our long-term strategy to support environmentally responsible growth, regulatory excellence, and reliable supply for customers worldwide.
As global demand for high-quality, ethically produced APIs continues to rise, we remain committed to advancing sustainable innovation, minimizing environmental impact, and contributing positively to the communities and industries we serve.